Canadian Cancer Society Launches Daffodil Month with $180K Research Grant for Bile Duct Cancer Vaccine
Event summary
- Canadian Cancer Society (CCS) launched its annual Daffodil Month campaign on March 25, 2026, featuring stories of hope from cancer survivors.
- Lead ambassador Léane Labrèche-Dor hosts a series of interviews with Quebecers affected by various cancers.
- CCS allocated $179,960 for research on custom vaccines against bile duct cancer at Université de Sherbrooke.
- Quebec has the highest cancer incidence rate in Canada, with new diagnoses expected to rise by 40% between 2015 and 2030.
The big picture
The Canadian Cancer Society's Daffodil Month campaign underscores the growing burden of cancer in an aging population, particularly in Quebec. With a 40% projected rise in new diagnoses by 2030, the organization is doubling down on research funding and public engagement to combat the disease. The $180K grant for bile duct cancer vaccines highlights a strategic focus on innovative treatments amid rising incidence rates.
What we're watching
- Funding Impact
- How the $180K grant will accelerate development of bile duct cancer vaccines and whether it can drive breakthroughs in treatment.
- Public Engagement
- The effectiveness of the Daffodil Month campaign in mobilizing public donations and awareness in Quebec.
- Cancer Trends
- The pace at which cancer incidence rates will rise in Quebec and whether CCS can scale support systems accordingly.
Related topics